[Thromboembolism--risk, prevention and therapy. Practice Guideline]

Orv Hetil. 2009 Dec 27;150(52):2335-404. doi: 10.1556/OH.2009.28789.
[Article in Hungarian]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Acute Disease
  • Anticoagulants / therapeutic use
  • Cardiovascular Diseases / complications
  • Chronic Disease
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Hungary
  • Internal Medicine / methods*
  • Mass Screening
  • Neoplasms / complications
  • Nervous System Diseases / complications
  • Platelet Aggregation Inhibitors / therapeutic use
  • Primary Prevention / methods*
  • Risk Assessment
  • Risk Factors
  • Secondary Prevention / methods
  • Surgical Procedures, Operative / adverse effects*
  • Thromboembolism / etiology
  • Thromboembolism / therapy
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / etiology*
  • Venous Thromboembolism / genetics
  • Venous Thromboembolism / prevention & control
  • Venous Thromboembolism / therapy*
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Vitamin K